194 related articles for article (PubMed ID: 22990556)
1. Cervical adenocarcinoma: a retrospective clinicopathologic study of 16 cases.
Barbu I; Crăiţoiu S; Mărgăritescu C
Rom J Morphol Embryol; 2012; 53(3):615-24. PubMed ID: 22990556
[TBL] [Abstract][Full Text] [Related]
2. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
[TBL] [Abstract][Full Text] [Related]
3. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
4. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix.
Kojima A; Mikami Y; Sudo T; Yamaguchi S; Kusanagi Y; Ito M; Nishimura R
Am J Surg Pathol; 2007 May; 31(5):664-72. PubMed ID: 17460448
[TBL] [Abstract][Full Text] [Related]
5. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
6. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
7. Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.
Togami S; Nomoto M; Higashi M; Goto M; Yonezawa S; Tsuji T; Batra SK; Douchi T
J Obstet Gynaecol Res; 2010 Jun; 36(3):588-97. PubMed ID: 20598042
[TBL] [Abstract][Full Text] [Related]
8. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
9. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
10. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
[TBL] [Abstract][Full Text] [Related]
11. Gross features of lobular endocervical glandular hyperplasia in comparison with minimal-deviation adenocarcinoma and stage Ib endocervical-type mucinous adenocarcinoma of the uterine cervix.
Sasajima Y; Mikami Y; Kaku T; Kiyokawa T; Ohishi Y; Hamada T; Sasaki T; Fujita H; Moriya T; Kasamatsu T; Tsuda H
Histopathology; 2008 Oct; 53(4):487-90. PubMed ID: 18631191
[No Abstract] [Full Text] [Related]
12. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology.
Sullivan LM; Smolkin ME; Frierson HF; Galgano MT
Am J Surg Pathol; 2008 Nov; 32(11):1608-12. PubMed ID: 18753946
[TBL] [Abstract][Full Text] [Related]
14. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.
Young RH; Clement PB
Histopathology; 2002 Sep; 41(3):185-207. PubMed ID: 12207781
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
[TBL] [Abstract][Full Text] [Related]
16. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
McCluggage WG; Sumathi VP; McBride HA; Patterson A
Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
[TBL] [Abstract][Full Text] [Related]
17. A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Wu TS; Cheng YW; Wang PH; Yue CH; Tyan YS
Arch Gynecol Obstet; 2010 May; 281(5):845-50. PubMed ID: 19847454
[TBL] [Abstract][Full Text] [Related]
18. [Histochemical analysis of uterine cervical adenocarcinoma with reference to mucosubstances and distribution of CEA, CA125 and CA19-9].
Maruyama C; Yamamichi N; Konishi F
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):429-36. PubMed ID: 3163714
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
Huang ZY; Zhang S; Zhang YZ; An JH; Luo J; Liao PJ; Chen Q; Shen H
Indian J Pathol Microbiol; 2018; 61(4):549-552. PubMed ID: 30303146
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]